Klaus Müller

Professor

Rigshospitalet

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Klaus Müller is a faculty member at Rigshospitalet in Denmark. His research focuses on pediatric hematopoietic stem cell transplantation, particularly in relation to dietary micronutrient intake, exercise motivation during cancer treatment, and the impact of chemotherapy on children with acute lymphoblastic leukemia. Recent articles authored by Professor Müller explore topics such as metabolic syndrome risks and chronic complications following stem cell transplantation.

Articles (25)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Pär Ingemar Johansson

Professor

University of Copenhagen

DENMARK

View details

Henrik Hasle

Professor

Aarhus Universitetshospital

DENMARK

View details

Henrik Sengelov

professor

University of Copenhagen

DENMARK

View details

Klaus Fuglsang Kofoed

DENMARK

View details

Mathias Rathe

DENMARK

View details

Jan Christensen

Københavns Universitet

DENMARK

View details

Maria Ebbesen Sørum

Københavns Universitet

DENMARK

View details

Anu Haavisto

University of Helsinki

FINLAND

View details

Päivi Maria Lähteenmäki

Karolinska Institutet

SWEDEN

View details

Claus Henrik Nielsen

Professor

University of Copenhagen

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Klaus Müller

Research Interests

Explore related searches

Contact this professor

About

Articles (25)

Dietary Micronutrient Intake in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation

Exploring Motivation for Engaging in Exercise During the First Six Months of Childhood Cancer Treatment: A Qualitative Study

Dietary intake and risk of metabolic syndrome in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation

Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia

Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study

Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training

Intestinal mucositis, systemic inflammation and bloodstream infections following high‐dose methotrexate treatment in childhood acute lymphoblastic leukaemia: Comparison between the <scp>NOPHO ALL</scp> 2008 protocol and the <scp>ALLTogether1</scp> protocol

Cytomegalovirus infection is associated with thymic dysfunction and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

Surfactant protein D is associated with pulmonary manifestations of chronic graft‐versus‐host disease following hematopoietic stem cell transplantation

Markers of neutrophil chemotaxis for identification of blood stream infections in children with acute lymphoblastic leukemia undergoing induction treatment

Gastrointestinal barrier integrity and mucosal inflammation as risk factors of blood stream infections in children treated for acute lymphoblastic leukaemia

Metabolic syndrome as a late effect of childhood hematopoietic stem cell transplantation - A thorough statistical evaluation of putative risk factors.

sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation.

Microdissection testicular sperm extraction after pediatric allogeneic hematopoietic stem cell transplantation: a case series.

Markers of intestinal mucositis to predict blood stream infections at the onset of fever during treatment for childhood acute leukemia.

Physical capacity in children and adolescents with newly diagnosed cancer: A systematic review and meta-analysis.

Highly-sensitive chimerism analysis in blood after allogeneic hematopoietic cell transplantation in childhood leukemia: Results from the Nordic Microchimerism Study

Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.

Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia.

Altered body composition in male long-term survivors of paediatric allogeneic haematopoietic stem cell transplantation: impact of conditioning regimen, chronic graft-versus-host disease and hypogonadism.

Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation.

Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study.

Male Gonadal Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Cross-Sectional, Population-Based Study.

Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota.

Is microchimerism a sign of imminent disease recurrence after allogeneic hematopoietic stem cell transplantation? A systematic review of the literature.

Collaborators (10)

Pär Ingemar Johansson

Henrik Hasle

Henrik Sengelov

Klaus Fuglsang Kofoed

Mathias Rathe

Jan Christensen

Maria Ebbesen Sørum

Anu Haavisto

Päivi Maria Lähteenmäki

Claus Henrik Nielsen

Make your next move.